Nintedanib overcomes drug resistance from upregulation of FGFR signalling and imatinib‐induced KIT mutations in gastrointestinal stromal tumours-Reference-Cited by-同舟云学术

Nintedanib overcomes drug resistance from upregulation of FGFR signalling and imatinib‐induced KIT mutations in gastrointestinal stromal tumours

Published:2022-03-06 Issue:8 Volume:16 Page:1761-1774
ISSN:1574-7891
Container-title:Molecular Oncology
language:en
Short-container-title:Molecular Oncology

Author:

Liu Juan¹²³,Gao Jingjing¹²,Wang Aoli¹³,Jiang Zongru¹³,Qi Shuang¹³,Qi Ziping¹³,Liu Feiyang¹³,Yu Kailin¹,Cao Jiangyan¹²,Chen Cheng¹,Hu Chen¹³,Wu Hong¹³,Wang Li¹³,Wang Wenchao¹³,Liu Qingsong¹²³⁴^ORCID,Liu Jing¹³

Affiliation:

1. Anhui Province Key Laboratory of Medical Physics and Technology, CAS Key Laboratory of High Magnetic Field and Ion Beam Physical Biology Institute of Health and Medical Technology Hefei Institutes of Physical Science Chinese Academy of Sciences Hefei China

2. University of Science and Technology of China Hefei China

3. Hefei Cancer Hospital Chinese Academy of Sciences Hefei China

4. Precision Medicine Research Laboratory of Anhui Province Hefei China

Funder

National Natural Science Foundation of China

Natural Science Foundation of Anhui Province

Publisher

Wiley

Subject

Cancer Research,Genetics,Molecular Medicine,General Medicine,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/1878-0261.13199